Amarin Corp plc (ADR) (NASDAQ:AMRN)

CAPS Rating: 3 out of 5

The Company is engaged in the research, development and commercialization of novel drugs for the treatment of central nervous system disorders.

Caps

How do you think AMRN will perform against the market?

Add Stock to CAPS Watchlist

All Players

336 Outperform
31 Underperform
 

All-Star Players

34 Outperform
8 Underperform
 

Wall Street

1 Outperform
1 Underperform
 

Top AMRN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

meridius91 (66.99)
Submitted September 27, 2018

After the recent approval of Vascepa, this stock is poised for greatness. With it's massive benefit to patients ON TOP of industry standard statins and relatively cheap price in comparison to alternatives on the market, Amarin could be at the front… More

chris293 (63.75)
Submitted May 07, 2013

FDA approval for fish oil? What else is going on here, are they selling the good parts of the company for what?

AMRN VS S&P 500 (SPY)

Fools bullish on AMRN are also bullish on:

Fools bearish on AMRN are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about AMRN.

Recs

0
Member Avatar EnigmaDude (59.46) Submitted: 10/2/2018 11:54:40 AM : Outperform Start Price: $15.62 AMRN Score: +33.59

potential blockbuster drug

Recs

0
Member Avatar pprimo (30.73) Submitted: 9/30/2018 12:55:44 PM : Outperform Start Price: $17.20 AMRN Score: +21.92

blockbuster drug Ascepa

Recs

1
Member Avatar meridius91 (66.99) Submitted: 9/27/2018 12:14:23 PM : Outperform Start Price: $14.21 AMRN Score: +46.06

After the recent approval of Vascepa, this stock is poised for greatness. With it's massive benefit to patients ON TOP of industry standard statins and relatively cheap price in comparison to alternatives on the market, Amarin could be at the front of paradigm shift at first level care.

Leaderboard

Find the members with the highest scoring picks in AMRN.

Score Leader

AWWWWW

AWWWWW (55.70) Score: +1,961.74

The Score Leader is the player with the highest score across all their picks in AMRN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
AWWWWW 55.70 12/31/2014 Outperform 1Y $0.95 +1,992.70% +30.96% +1,961.74 0 Comment
Playa14 < 20 12/26/2014 Outperform 5Y $0.99 +1,902.02% +30.85% +1,871.17 0 Comment
efarev 98.71 2/3/2015 Outperform 5Y $1.03 +1,824.27% +33.66% +1,790.62 0 Comment
BENIVZ14 < 20 12/15/2014 Outperform 5Y $1.09 +1,718.35% +34.95% +1,683.40 0 Comment
rantomac 70.99 2/10/2015 10/31/2017 Outperform 5Y $1.12 +1,669.64% +32.39% +1,637.25 0 Comment
GoPack 38.91 11/21/2014 Outperform 5Y $1.28 +1,448.44% +31.27% +1,417.17 0 Comment
jamesjass < 20 9/17/2014 Outperform 1Y $1.33 +1,390.23% +35.76% +1,354.46 0 Comment
pro64grammer 29.45 9/12/2014 Outperform 5Y $1.40 +1,320.79% +36.41% +1,284.38 0 Comment
velo15 < 20 3/31/2016 Outperform 5Y $1.51 +1,212.58% +32.37% +1,180.21 0 Comment
surfco3 78.38 4/6/2016 Outperform 5Y $1.59 +1,146.54% +33.42% +1,113.12 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 85.31 1/3/2013 Underperform 3W $8.38 +136.52% +87.04% -49.48 0 Comment
TrackPoisedTo < 20 12/20/2012 Outperform 5Y $8.42 +135.39% +88.79% +46.61 0 Comment
TrackCitigroup 89.67 4/30/2012 Outperform NS $12.50 -88.32% +35.24% -123.56 5/12/2014 @ $1.46 0 Comment
TrackJimCramer 85.31 3/22/2012 Outperform 3W $11.91 -29.64% +4.69% -34.33 1/3/2013 @ $8.38 0 Comment
TrackMKMPartners 89.03 7/12/2011 Outperform NS $14.24 -84.34% +39.55% -123.89 1/16/2014 @ $2.23 0 Comment
TrackCanaccord 63.53 4/18/2011 Outperform NS $16.51 -87.95% +32.92% -120.87 10/18/2013 @ $1.99 0 Comment
TrackWedbush 87.32 7/20/2010 Outperform NS $2.23 +418.39% +37.21% +381.18 10/3/2012 @ $11.56 0 Comment

Advertisement